Blog
RSS FeedPosted by Michael Wonder on 22 Aug 2022
Hansa Biopharma and Medison Pharma announce positive reimbursement decision in Poland for Idefirix in highly sensitised kidney transplant patients
22 August 2022 - Reimbursement follows the inclusion of Idefirix on the shortlist for exceptional innovative treatments with special funding. ...